Drugs / CDP
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01002092 Background | Feb 2009 → Dec 2014 | osteosarcoma | Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CDP | “Week 3 day 1-2 CDP 100-120 mg/m2” NCT01002092 ↗ |